Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, Aileron, Anixa, Astrazeneca, Atara, Biogen, BMS, Boehringer, Cocrystal, Codagenix, Corvus, Covis, Effector, Essa, Exelixis, Foghorn, Hepion, Horizon, Immutep, Jaguar, Kura, Merck, Merus, Morphic, Nurix, Olema, Oncopeptides, Redhill, Ryvu, Viiv.